Supplemental material
Leukemia & Lymphoma
Volume 65, 2024 - Issue 5
Open access
1,893
Views
0
CrossRef citations to date
0
Altmetric
Review Articles
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations
Naveen Pemmarajua The University of Texas MD Anderson Cancer Center, Houston, Texas, USACorrespondence[email protected]
https://orcid.org/0000-0002-1670-6513View further author information
Yazan F. Madanatb UT Southwestern Medical Center, Dallas, Texas, USA
https://orcid.org/0000-0001-9573-2690View further author information
David Rizzieric Novant Health Cancer Institute, Winston Salem, North Carolina, USA
https://orcid.org/0000-0001-9886-5771View further author information
Salman Fazald Allegheny Health Network, Pittsburgh, Pennsylvania, USAView further author information
, Raajit Rampale Memorial Sloan Kettering Cancer Center, New York, New York, USA
https://orcid.org/0000-0002-0355-6368View further author information
Gabriel Mannisf Stanford Medicine, Palo Alto, California, USAView further author information
, Eunice S. Wangg Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
https://orcid.org/0000-0002-8644-0968View further author information
James Foranh Mayo Clinic Cancer Center, Jacksonville, Florida, USA
https://orcid.org/0000-0003-1673-1708View further author information
Andrew A. Lanei Dana-Farber Cancer Institute, Boston, Massachusetts, USA
https://orcid.org/0000-0001-7380-0226View further author information
Pages 548-559
|
Received 09 Jun 2023, Accepted 09 Jan 2024, Published online: 23 Feb 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.